Search research articles
Contact Us
Filters
Showing results (51-60 of 1,111) with videos related to
Page
of 112
Sort By:
Anti-Cancer Drug Design
|
February 1, 1993
Growth inhibition of human tumor cell lines by antisense oligonucleotides designed to inhibit p120 expression
L Perlaky, Y Saijo, R K Busch, et al.
Cancer Research
|
October 15, 1992
A region of antisense RNA from human p120 cDNA with high homology to mouse p120 cDNA inhibits NIH 3T3 proliferation
B C Valdez, L Perlaky, Y Saijo, et al.
Nucleic Acids Research
|
April 1, 1996
A nucleolar RNA helicase recognized by autoimmune antibodies from a patient with watermelon stomach disease
B C Valdez, D Henning, R K Busch, et al.
Cancer Research
|
September 1, 1976
Antigenically active nonhistone chromatin proteins in cancer cells
H Busch, L C Yeoman, R K Busch, et al.
Transplantation Proceedings
|
March 1, 1980
A nucleolar antigen in human malignant tumors
H Busch, R K Busch, P K Chan, et al.
Cancer Communications
|
January 1, 1989
Proliferation-related nucleolar antigens P145 and P120 associated with separate nucleolar elements and differences in tissue distribution
J W Freeman, J E Hazlewood, V Bondada, et al.
Cancer Research
|
July 1, 1986
Identification and partial characterization of a nucleolar antigen with a molecular weight of 145,000 found in a broad range of human cancers
J W Freeman, D K McRorie, R K Busch, et al.
Cancer Research
|
January 15, 1992
Increased growth of NIH/3T3 cells by transfection with human p120 complementary DNA and inhibition by a p120 antisense construct
L Perlaky, B C Valdez, R K Busch, et al.
The Journal of Rheumatology. Supplement
|
June 1, 1987
Novel nucleolar antigens in autoimmune disease
H Busch, R K Busch, A Black, et al.
Cancer Investigation
|
January 1, 1983
Ultrastructural and purification studies on human tumor nucleolar antigens and nucleolar particles
H Busch, R K Busch, P K Chan, et al.
Page
of 112
Search research articles
Search
Showing results (51-60 of 1,111) with videos related to
Sort By:
Page
of 112
Anti-Cancer Drug Design
|
February 1, 1993
Growth inhibition of human tumor cell lines by antisense oligonucleotides designed to inhibit p120 expression
L Perlaky, Y Saijo, R K Busch, et al.
Cancer Research
|
October 15, 1992
A region of antisense RNA from human p120 cDNA with high homology to mouse p120 cDNA inhibits NIH 3T3 proliferation
B C Valdez, L Perlaky, Y Saijo, et al.
Nucleic Acids Research
|
April 1, 1996
A nucleolar RNA helicase recognized by autoimmune antibodies from a patient with watermelon stomach disease
B C Valdez, D Henning, R K Busch, et al.
Cancer Research
|
September 1, 1976
Antigenically active nonhistone chromatin proteins in cancer cells
H Busch, L C Yeoman, R K Busch, et al.
Transplantation Proceedings
|
March 1, 1980
A nucleolar antigen in human malignant tumors
H Busch, R K Busch, P K Chan, et al.
Cancer Communications
|
January 1, 1989
Proliferation-related nucleolar antigens P145 and P120 associated with separate nucleolar elements and differences in tissue distribution
J W Freeman, J E Hazlewood, V Bondada, et al.
Cancer Research
|
July 1, 1986
Identification and partial characterization of a nucleolar antigen with a molecular weight of 145,000 found in a broad range of human cancers
J W Freeman, D K McRorie, R K Busch, et al.
Cancer Research
|
January 15, 1992
Increased growth of NIH/3T3 cells by transfection with human p120 complementary DNA and inhibition by a p120 antisense construct
L Perlaky, B C Valdez, R K Busch, et al.
The Journal of Rheumatology. Supplement
|
June 1, 1987
Novel nucleolar antigens in autoimmune disease
H Busch, R K Busch, A Black, et al.
Cancer Investigation
|
January 1, 1983
Ultrastructural and purification studies on human tumor nucleolar antigens and nucleolar particles
H Busch, R K Busch, P K Chan, et al.
Page
of 112